Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07444892) titled 'Levodopa for Diabetic Retinopathy' on Feb. 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Investigator).

Primary Sponsor: Emory University

Condition: Diabetic Retinopathy

Intervention: Drug: Levodopa

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: April 18, 2022

Target Sample Size: 230

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07444892

Published by HT Digital Content Services with permission from He...